This review highlights the varying gastrointestinal and cardiovascular risks of NSAIDs and emphasizes the need for individualized treatment algorithms.
No takes yet. Share an insight, caveat, or question.
Reinforces NSAID risk awareness for individualized prescribing; leaves open prospective validation of decision algorithms.
Philip G. Conaghan (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: